NHL three-time Stanley Cup winner Malkin still hopes to play for Russia at 2018 GamesSport July 27, 15:33
Brazilian football team’s staff kick off Russian language practice ahead of 2018 World CupSport July 27, 14:48
Kremlin explains why commenting on new US envoy pick would be inappropriate nowRussian Politics & Diplomacy July 27, 14:37
Kremlin comments on EU sanctions against RussiaRussian Politics & Diplomacy July 27, 14:36
Russian, Finnish presidents to discuss stability, security in Baltic regionWorld July 27, 14:24
Putin appoints Russia’s permanent representative to UNRussian Politics & Diplomacy July 27, 13:41
CEO vows Shell will strive to honor its Nord Stream 2 commitmentsBusiness & Economy July 27, 13:31
Yandex may be fined for advertising itself as 'number one in Russia'Business & Economy July 27, 13:28
Russian airborne divisions get advanced portable air defense systemsMilitary & Defense July 27, 13:20
NOVOSIBIRSK, June 9. /TASS/. A new vaccine to protect against Ebola virus disease developed by Russia’s Vector research center of virology and biotechnology has successfully undergone the first stage of clinical tests, the acting director general of the research center told reporters on the sidelines of the international forum for technological development on Thursday.
"The first phase of clinical tests has been completed. It is now on approval at the Russian Ministry of Healthcare. We are waiting for a second phase," Valery Mikheyev said.
According to the World Health Organization (WHO), more than 11,300 people have died from Ebola in West Africa, primarily in Guinea, Sierra Leone and Liberia. More than 28,600 were infected. In January, Russia informed the WHO executive committee about its anti-Ebola vaccines.
The World Health Organization describes Ebola virus disease (formerly known as Ebola haemorrhagic fever) as "a severe, often fatal illness, with a case fatality rate of up to 90%." Until now, there has been no known cure or vaccine for the disease. The only treatment offered is "supportive intensive care." During an outbreak, those at higher risk of infection are health workers, family members and others in close contact with sick people and deceased patients.